Concepedia

Susan Light

SL

19

Publications

2.5K

Citations

17

H-Index

1977

Active since

Affiliations

University of California, San Francisco(Current)

La Roche College

Medizinische Hochschule Hannover

Indiana University – Purdue University Indianapolis

University of Alabama at Birmingham

Susan Light is an author at University of California, San Francisco specializing in medicine, immunology, and pathology.

Top concepts

Publications per year

1977–2016

19

Publications

19

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

F. Vincenti, Robert L. Kirkman, Susan Light et al. · New England Journal of Medicine · 1998 · 875 citations · Full text

REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1

Björn Nashan, Susan Light, Ian R. Hardie et al. · Transplantation · 1999 · 308 citations

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti et al. · Blood · 2000 · 240 citations

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti et al. · Blood · 2000 · 238 citations

A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1

Flavio Vincenti, Marianne Lantz, Jytte L. Birnbaum et al. · Transplantation · 1997 · 147 citations

Rows per page

1–5 of 19